HUNTINGTON NATIONAL BANK - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 1 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$010.0%0.00%
Q2 2023$010.0%0.00%
Q1 2023$010.0%0.00%
Q4 2022$010.0%0.00%
Q3 2022$010.0%0.00%
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$010.0%0.00%
Q3 2021$010.0%0.00%
Q2 2021$010.0%0.00%
Q1 2021$010.0%0.00%
Q4 2020$010.0%0.00%
Q3 2020$010.0%0.00%
Q2 2020$010.0%0.00%
Q1 2020$010.0%0.00%
Q4 2019$010.0%0.00%
Q3 2019$010.0%0.00%
Q2 2019$010.0%0.00%
Q4 2018$010.0%0.00%
Q3 2018$0
-100.0%
1
-100.0%
0.00%
-100.0%
Q1 2016$29,000
+70.6%
3,689
+9.8%
0.00%
Q2 2015$17,000
-41.4%
3,360
-8.9%
0.00%
-100.0%
Q1 2015$29,000
+31.8%
3,6890.0%0.00%0.0%
Q4 2014$22,0003,689
+570.7%
0.00%
Q2 2011$0
-100.0%
5500.0%0.00%
Q1 2011$2,000
-50.0%
5500.0%0.00%
Q4 2010$4,0005500.00%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 5,427,559$2,334,0001.60%
Scale Management, LLC 1,312,575$564,0001.34%
Foresite Capital Management III, LLC 2,542,575$1,093,0000.75%
BVF INC/IL 5,252,100$2,258,0000.48%
TIVERTON ASSET MANAGEMENT LLC 45,313$4,261,0000.18%
Baupost Group 22,268,399$9,575,0000.13%
Rhenman & Partners Asset Management AB 1,200,000$516,0000.09%
NEA Management Company, LLC 370,900$1,595,0000.08%
SAMLYN CAPITAL, LLC 6,160,417$2,649,0000.06%
Palo Alto Investors LP 1,673,024$719,0000.05%
View complete list of OREXIGEN THERAPEUTICS INC shareholders